Search Legislation

Advanced Search

Commission Directive 2006/17/ECShow full title

Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells (Text with EEA relevance)

Help about what version

What Version

More Resources

Revised version PDFs

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Status:

EU Directives are being published on this site to aid cross referencing from UK legislation. After IP completion day (31 December 2020 11pm) no further amendments will be applied to this version.

  1. Introductory Text

  2. Article 1.Definitions

  3. Article 2.Requirements for the procurement of human tissues and cells

  4. Article 3.Selection criteria for donors of tissues and cells

  5. Article 4.Laboratory tests required for donors

  6. Article 5.Tissue and/or cell donation and procurement procedures and reception at the tissue establishment

  7. Article 6.Requirements for direct distribution to the recipient of specific tissues and cells

  8. Article 7.Transposition

  9. Article 8.Entry into force

  10. Article 9.Addressees

    1. ANNEX I

      SELECTION CRITERIA FOR DONORS OF TISSUES AND/OR CELLS (EXCEPT DONORS OF REPRODUCTIVE CELLS) AS REFERRED TO IN ARTICLE 3(a)

      1. Selection criteria for donors are based on an analysis of...

      2. 1. Deceased Donors

        1. 1.1. General criteria for exclusion

          1. 1.1.1. Cause of death unknown, unless autopsy provides information on the...

          2. 1.1.2. History of a disease of unknown aetiology.

          3. 1.1.3. Presence, or previous history, of malignant disease, except for primary...

          4. 1.1.4. Risk of transmission of diseases caused by prions. This risk...

          5. 1.1.5. Systemic infection which is not controlled at the time of...

          6. 1.1.6. History, clinical evidence, or laboratory evidence of HIV, acute or...

          7. 1.1.7. History of chronic, systemic autoimmune disease that could have a...

          8. 1.1.8. Indications that test results of donor blood samples will be...

          9. 1.1.9. Evidence of any other risk factors for transmissible diseases on...

          10. 1.1.10. Presence on the donor’s body of physical signs implying a...

          11. 1.1.11. Ingestion of, or exposure to, a substance (such as cyanide,...

          12. 1.1.12. Recent history of vaccination with a live attenuated virus where...

          13. 1.1.13. Transplantation with xenografts.

        2. 1.2. Additional exclusion criteria for deceased child donors

          1. 1.2.1. Any children born from mothers with HIV infection or that...

      3. 2. Living donors

        1. 2.1. Autologous living donor

          1. 2.1.1. If the removed tissues and cells are to be stored...

        2. 2.2. Allogeneic living donor

          1. 2.2.1. Allogeneic living donors must be selected on the basis of...

          2. 2.2.2. Selection criteria for allogeneic living donors must be established and...

          3. 2.2.3. The same exclusion criteria must be applied as for deceased...

    2. ANNEX II

      LABORATORY TESTS REQUIRED FOR DONORS (EXCEPT DONORS OF REPRODUCTIVE CELLS) AS REFERRED TO IN ARTICLE 4(1)

      1. 1. Biological tests required for donors

        1. 1.1. The following biological tests must be performed for all donors...

        2. 1.2. HTLV-I antibody testing must be performed for donors living in,...

        3. 1.3. When anti-HBc is positive and HBsAg is negative, further investigations...

        4. 1.4. A validated testing algorithm must be applied to exclude the...

        5. 1.5. In certain circumstances, additional testing may be required depending on...

        6. 1.6. For autologous donors, Annex I, point 2.1.1, applies.

      2. 2. General requirements to be met for determining biological markers

        1. 2.1. The tests must be carried out by a qualified laboratory,...

        2. 2.2. The biological tests will be carried out on the donor’s...

        3. 2.3. When potential donors have lost blood and have recently received...

        4. 2.4. In the case of a deceased donor, blood samples must...

        5. 2.5. In the case of living donors (except allogeneic bone marrow...

        6. 2.6. If in a living donor (except bone marrow stem-cell and...

        7. 2.7. In the case of bone marrow and peripheral blood stem-cell...

        8. 2.8. In the case of neonatal donors, the biological tests may...

    3. ANNEX III

      SELECTION CRITERIA AND LABORATORY TESTS REQUIRED FOR DONORS OF REPRODUCTIVE CELLS AS REFERRED TO IN ARTICLE 3(b) AND ARTICLE 4(2)

      1. 1. Partner donation for direct use

      2. 2. Partner donation (not direct use)

      3. 3. Donations other than by partners

      4. 4. General requirements to be met for determining biological markers

        1. 4.1. The tests must be carried out in accordance with Annex...

        2. 4.2. For donations other than by partners, blood samples must be...

        3. 4.3. Sperm donations other than by partners will be quarantined for...

    4. ANNEX IV

      CELL AND/OR TISSUE DONATION AND PROCUREMENT PROCEDURES AND RECEPTION AT THE TISSUE ESTABLISHMENT AS REFERRED TO IN ARTICLE 5

      1. 1. Donation and procurement procedures

        1. 1.1. Consent and donor identification

          1. 1.1.1. Before the procurement of tissues and cells proceeds, an authorised...

          2. 1.1.2. In the case of living donors, the health professional responsible...

        2. 1.2. Donor evaluation (this section does not apply to partner donation...

          1. 1.2.1. An authorised person must collect and record the donor’s relevant...

          2. 1.2.2. In order to acquire the appropriate information, different relevant sources...

          3. 1.2.3. In addition, in the case of a deceased donor, and...

          4. 1.2.4. The complete donor records must be reviewed and assessed for...

        3. 1.3. Procurement procedures for tissues and cells

          1. 1.3.1. The procurement procedures must be appropriate for the type of...

          2. 1.3.2. The procurement procedures must protect those properties of the tissue/cells...

          3. 1.3.3. For deceased donation, the area of access must be restricted....

          4. 1.3.4. In the case of a deceased donor, the place of...

          5. 1.3.5. Once the tissues and cells have been retrieved from a...

          6. 1.3.6. Any adverse event occurring during procurement that has or may...

          7. 1.3.7. Policies and procedures must be in place to minimise the...

          8. 1.3.8. Sterile instruments and devices must be used for tissue and...

          9. 1.3.9. When reusable instruments must be used, a validated cleaning and...

          10. 1.3.10. Wherever possible, only CE marked medical devices must be used...

        4. 1.4. Donor documentation

          1. 1.4.1. For each donor, there must be a record containing:

          2. 1.4.2. The organisation performing the procurement must produce a procurement report,...

          3. 1.4.3. All the records must be clear and readable, protected from...

          4. 1.4.4. Donor records required for full traceability must be kept for...

        5. 1.5. Packaging

          1. 1.5.1. Following procurement, all recovered tissues and cells must be packaged...

          2. 1.5.2. The packaged cells/tissues must be shipped in a container which...

          3. 1.5.3. Any accompanying tissue or blood samples for testing must be...

        6. 1.6. Labelling of the procured tissues/cells

        7. 1.7. Labelling of the shipping container

      2. 2. Reception of the tissue/cells at the tissue establishment

        1. 2.1. When the retrieved tissues/cells arrive at the tissue establishment, there...

        2. 2.2. Each establishment must ensure that the tissue and cells received...

        3. 2.3. Each tissue establishment must have a documented policy and specifications...

        4. 2.4. The data that must be registered at the tissue establishment...

        5. 2.5. In the case of reproductive cells intended for partner donation,...

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources